Sign In
Buy JNJ
$241.00
+1.92 (+0.80%)
At Close: Jun 24, 2026
J&J Drops Out Of A Key Race, Leaving Pfizer, GSK, Moderna To Duke It Out
08:48am, Friday, 31'st Mar 2023
Johnson & Johnson ducked out of the RSV vaccine race Wednesday, leaving Pfizer, GSK and Moderna to duke it out. The post J&J Drops Out Of A Key Race, Leaving Pfizer, GSK, Moderna To Duke It Out appear
2 Unstoppable Stocks to Buy Without Hesitation Right Now
01:20pm, Thursday, 30'th Mar 2023 The Motley Fool
These industry giants are going from strength to strength in a volatile market.
Should Schwab U.S. Large-Cap Value ETF (SCHV) Be on Your Investing Radar?
10:20am, Thursday, 30'th Mar 2023 Zacks Investment Research
Style Box ETF report for SCHV
8 Defensive Dividend Stars That Could Help You Retire Rich
09:30am, Thursday, 30'th Mar 2023
Most people are far behind on their retirement goals - often without realizing it. In this article, I present conservative dividend growth investing as a suitable way to achieve long-term financial go
2 Unstoppable Stocks to Buy Without Hesitation Right Now
09:20am, Thursday, 30'th Mar 2023
Healthcare and travel are industries with long-term trajectories for growth that can outlast any recessionary headwinds. Johnson & Johnson is a healthcare giant with a superior track record of rewardi
Best Blue Chip Stocks To Invest In Right Now? 3 To Know
04:04pm, Wednesday, 29'th Mar 2023
Three blue chip stocks to watch today.
Benzinga's Top Ratings Upgrades, Downgrades For March 29, 2023
03:00pm, Wednesday, 29'th Mar 2023 Benzinga
Upgrades
According to Sidoti & Co., the prior rating for Federal Agricultural Mortgage Corp (NYSE:AGM) was changed from Neutral to Buy. In the fourth quarter, Federal Agricultural showed an EPS of $3.
Analyst Expectations for Johnson & Johnson's Future
02:01pm, Wednesday, 29'th Mar 2023 Benzinga
Over the past 3 months, 6 analysts have published their opinion on Johnson & Johnson (NYSE:JNJ) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a
J&J backs out of RSV vaccine race with rivals Pfizer and GSK
12:28pm, Wednesday, 29'th Mar 2023
J&J lagged behind rival drugmakers Pfizer and GSK, both of which made major strides toward U.S. approval of their RSV vaccines in the last month.
Got $5,000? These 2 Blue Chip Stocks Are Near Multi-Year Lows
12:10pm, Wednesday, 29'th Mar 2023 The Motley Fool
Both of these stocks also provide investors with attractive dividend yields of around 3%.
J&J Drops Out Of A Key Race, Leaving Pfizer, GSK, Moderna To Duke It Out
11:05am, Wednesday, 29'th Mar 2023
Johnson & Johnson ducked out of the RSV vaccine race Wednesday, leaving Pfizer, GSK and Moderna to duke it out. The post J&J Drops Out Of A Key Race, Leaving Pfizer, GSK, Moderna To Duke It Out appear
Is It Time to Buy the Dow Jones' 3 Worst-Performing Stocks This Year?
09:33am, Wednesday, 29'th Mar 2023 The Motley Fool
Curious about the "dogs of the Dow" in 2023? Here's what's happening in the darkest corner of Wall Street's most exclusive club.
Got $5,000? These 2 Blue Chip Stocks Are Near Multi-Year Lows
08:10am, Wednesday, 29'th Mar 2023
Johnson & Johnson's stock has been struggling, as a judge recently thwarted the company's efforts to bankrupt a subsidiary to limit the cost of its talc lawsuits. Home Depot doesn't expect any growth
7 Dividend Aristocrats to Buy for Consistent Income Growth
02:29pm, Tuesday, 28'th Mar 2023
I'd argue there's never been a better time to consider investing in dividend aristocrats. Volatility remains very high in the overall market, with a destabilized banking sector.
Could This Drug Candidate Be a Winner for These 2 Big Pharma Stocks?
02:15pm, Tuesday, 28'th Mar 2023 The Motley Fool
These titans of big pharma just enrolled patients into phase 3 clinical trials for this promising blood thinner.
